Related Experiment Video

Updated: Apr 30, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K

Correction: Gonzalez et al. Principles of Surgical Treatment of Soft Tissue Sarcomas. Cancers 2025, 17, 401

Marcos R Gonzalez1, Carolina Mendez-Guerra2, Megan H Goh1

  • 1Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.

Cancers
|July 12, 2025
PubMed

Abstract:

In the original publication [...].

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K

Related Experiment Videos

Last Updated: Apr 30, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

Articles linked to this work by shared authors, journal, and citation graph.

Oncologic Outcomes After Extra-Articular Resection of Bone and Soft Tissue Sarcomas Involving Major Joints: A Systematic Review.

Cancers·2026

Functional Outcomes by Ethnicity and Sex Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis of the Parity Trial.

The Journal of the American Academy of Orthopaedic Surgeons·2026

Long-term Oncologic Outcomes After Unplanned Soft Tissue Sarcoma Surgery: Implications for Surveillance Strategies.

Clinical orthopaedics and related research·2026

Circulating Tumor Cells in Soft Tissue Sarcoma: Current Evidence and Clinical Implications.

Cancers·2026

Enhancing Osteosarcoma Survival Predictions: A Comparative Study of a Multicomponent-Model Machine Learning Approach Integrating SEER and NCDB Data Sets Versus Conventional Single-Data-Set Modeling.

The Journal of bone and joint surgery. American volume·2026

Effect of Timing of First Consultation with a Sarcoma Specialist Following Unplanned Excision: Oncologic Outcomes of Patients with Soft-Tissue Sarcomas.

The Journal of bone and joint surgery. American volume·2026

Ultrasound-Activated Microbubbles for Precision Chemo-Radioenhancement in Prostate Cancer: Sonoporation, Therapeutic Synergy, and Translational Pathways.

Cancers·2026

Safety and Feasibility of Endoscopic-Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer: An Exploratory Randomised Clinical Trial.

Cancers·2026

Treatment-Induced PD-L1 Dynamics and Temporal Heterogeneity in Locally Advanced and Metastatic Gastroesophageal Cancer-A Systematic Review.

Cancers·2026

Distinct Bone Marrow Metabolic Profiles at Relapse Compared with Initial Diagnosis in Pediatric Acute Lymphoblastic Leukemia-An LC-MS Metabolomics Study.

Cancers·2026

Colorectal Cancer in Younger and Elderly Patients: A Real-World Analysis from the Modena Cancer Center.

Cancers·2026

Fatty Acid Heterogeneity in Colorectal Cancer: From Food Matrices to Targeted Interventions.

Cancers·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us